In-vitro dissolution testing of 5-aminosalicylic acid release from pH dependent mesalazine formulations

被引：0
|
作者：
Kruis, Wolfgang [2 ]
Greinwald, Roland [1 ]
Fingerhut, Thomas [3 ]
机构：
[1] Dr Falk Pharma GmbH, Res & Dev, Freiburg, Germany
[2] Univ Cologne, Evangel Krankenhaus Kalk, Cologne, Germany
[3] Dr Falk Pharma GmbH, Qual Assurance & Qual Control, Freiburg, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2011年 / 5卷 / 05期
关键词：
ACTIVE ULCERATIVE-COLITIS; DOUBLE-BLIND; PELLETS; TABLETS; TRIAL;
D O I：
10.1016/j.crohns.2011.04.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：499 / 500
页数：2
相关论文
共 50 条
  • [21] Acute pancreatitis caused by 5-aminosalicylic acid (mesalazine) administered orally or by enema!!
    Schwörer, H
    Ramadori, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (44) : 1328 - 1330
  • [22] Features of drugs used in inflammatory bowel disease: 5-aminosalicylic acid (mesalazine)
    Klotz, U.
    IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE, 2008, 159 : 145 - 152
  • [23] Preparation and in-vitro characterization of 5-aminosalicylic acid loaded hydrogels for colon specific delivery
    Suhail, Muhammad
    Hung, Ming-Chia
    Chiu, I. -Hui
    Vu, Quoc Lam
    Wu, Pao -Chu
    JOURNAL OF MATERIALS RESEARCH AND TECHNOLOGY-JMR&T, 2022, 21 : 339 - 352
  • [24] DELAYED-RELEASE 5-AMINOSALICYLIC ACID (5-ASA) - COAT DISSOLUTION AND EXCRETION IN ILEOSTOMY SUBJECTS
    RILEY, SA
    TAVARES, LA
    BENNET, A
    MANI, V
    GASTROENTEROLOGY, 1988, 94 (05) : A377 - A377
  • [25] COMPARISON OF DELAYED-RELEASE 5-AMINOSALICYLIC ACID (MESALAZINE) AND SULFASALAZINE AS MAINTENANCE TREATMENT FOR PATIENTS WITH ULCERATIVE-COLITIS
    RILEY, SA
    MANI, V
    GOODMAN, MJ
    HERD, ME
    DUTT, S
    TURNBERG, LA
    GASTROENTEROLOGY, 1988, 94 (06) : 1383 - 1389
  • [26] AVAILABILITY OF MESALAZINE (5-AMINOSALICYLIC ACID) FROM ENEMAS AND SUPPOSITORIES DURING STEADY-STATE CONDITIONS
    JACOBSEN, BA
    ABILDGAARD, K
    RASMUSSEN, HH
    CHRISTENSEN, LA
    FALLINGBORG, J
    HANSEN, SH
    RASMUSSEN, SN
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (04) : 374 - 378
  • [27] Comparative cytotoxicity of 5-aminosalicylic acid (mesalazine) and related compounds in different cell lines
    Noble, E
    Janssen, L
    Dierickx, PJ
    CELL BIOLOGY AND TOXICOLOGY, 1997, 13 (06) : 445 - 451
  • [28] SEVERE SIDE-EFFECTS WITH THE APPLICATION OF MESALAZINE (5-AMINOSALICYLIC ACID) DURING RADIOTHERAPY
    FREUND, U
    SCHOLMERICH, J
    SIEMS, H
    KLUGE, F
    SCHAFER, HE
    WANNENMACHER, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1987, 163 (10): : 678 - 680
  • [29] Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
    Sener, Aziz
    Sahbaz, Alper
    Sener, Leyla Turker
    Tekkesin, Merva Soluk
    Kaya, Bulent
    NORTHERN CLINICS OF ISTANBUL, 2018, 5 (03) : 171 - 175
  • [30] COMPARISON OF DELAYED-RELEASE 5-AMINOSALICYLIC ACID (MESALAZINE) AND SULFASALAZINE AS MAINTENANCE TREATMENT FOR PATIENTS WITH ULCERATIVE-COLITIS
    BREUER, N
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1989, 27 (04): : 234 - 235
12345